The role of T and B cells in atherosclerosis: potential clinical implications.

Current pharmaceutical design

Volumn 17, Issue 37, 2011, Pages 4159-4171

  Dumitriu, I E ^a   Kaski, J C ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADAPTIVE IMMUNITY; ANIMAL; ATHEROSCLEROSIS; B LYMPHOCYTE; DRUG EFFECT; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; REVIEW; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, MONOCLONAL; ATHEROSCLEROSIS; B-LYMPHOCYTES; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNITY, INNATE; IMMUNOSUPPRESSIVE AGENTS; T-LYMPHOCYTES;

EID: 84861313674     PISSN: None     EISSN: 18734286     Source Type: Journal    
DOI: None     Document Type: Review

References (0)